Mechanisms of congenital cytomegalovirus-induced deafness

Drug Discovery Today: Disease Mechanisms

Volumn 3, Issue 1, 2006, Pages 105-113

  Schleiss, Mark R ^a   Choo, Daniel I ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; CYTOMEGALOVIRUS ANTIGEN PP65; CYTOMEGALOVIRUS VACCINE; G PROTEIN COUPLED RECEPTOR; GANCICLOVIR; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TUMOR NECROSIS FACTOR RECEPTOR; VALGANCICLOVIR;

BACTERIAL MENINGITIS; CLINICAL TRIAL; CONGENITAL DEAFNESS; CONGENITAL INFECTION; CONGENITAL RUBELLA SYNDROME; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFICACY; DRUG TOLERABILITY; HIGH RISK POPULATION; HUMAN; IMMUNOPATHOGENESIS; INCIDENCE; INFECTION RATE; INFECTION RISK; INTERMETHOD COMPARISON; LABYRINTHITIS; NEWBORN; NEWBORN INFECTION; NEWBORN SCREENING; NONHUMAN; NUCLEOTIDE SEQUENCE; PERCEPTION DEAFNESS; POLYMERASE CHAIN REACTION; REVIEW; RISK REDUCTION; VACCINATION; VIRUS GENOME; VIRUS IMMUNITY; VIRUS LOAD; VIRUS PATHOGENESIS; VIRUS TRANSMISSION;

EID: 33746073386     PISSN: 17406765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmec.2006.02.009     Document Type: Review

References (72)

1. Whitley R.J. Congenital cytomegalovirus infection: epidemiology and treatment. Adv. Exp. Med. Biol. 549 (2004) 155-160
2. Griffiths P.D., and Walter S. Cytomegalovirus. Curr. Opin. Infect. Dis. 18 (2005) 241-245
3. Schleiss M.R. Vertically transmitted herpesvirus infections. Herpes 10 (2003) 4-11
4. Bale J.F., et al. Congenital cytomegalovirus infection. Curr. Treat Options Neurol. 4 (2002) 225-230
5. Rock R.B., et al. Role of microglia in central nervous system infections. Clin. Microbiol. Rev. 17 (2004) 942-964
6. Pass R.F., et al. Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J. Clin. Virol. 35 (2006) 216-220
7. Pass R.F. Congenital cytomegalovirus infection and hearing loss. Herpes 12 (2005) 50-55
8. Fowler K.B., et al. Maternal age and congenital cytomegalovirus infection: screening of two diverse newborn populations, 1980-1990. J. Infect. Dis. 168 (1993) 552-556
9. Peckham C.S., et al. Congenital cytomegalovirus infection: a cause of sensorineural hearing loss. Arch. Dis. Child. 62 (1987) 1233-1237
10. Hicks T., et al. Congenital cytomegalovirus infection and neonatal auditory screening. J. Pediatr. 123 (1993) 779-782
11. Barbi M., et al. A wider role for congenital cytomegalovirus infection in sensorineural hearing loss. Pediatr. Infect. Dis. J. 22 (2003) 39-42
12. Fowler K.B., et al. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J. Pediatr. 130 (1997) 624-630
13. Dahle A.J., et al. Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J. Am. Acad. Audiol. 11 (2000) 283-290
14. Noyola D.E., et al. Cytomegalovirus urinary excretion and long term outcome in children with congenital cytomegalovirus infection. Congenital CMV Longitudinal Study Group. Pediatr. Infect. Dis. J. 19 (2000) 505-510
15. Madden C., et al. Audiometric, clinical and educational outcomes in a pediatric symptomatic congenital cytomegalovirus (CMV) population with sensorineural hearing loss. Int. J. Pediatr. Otorhinolaryngol. 69 (2005) 1191-1198
16. Johansson P.J., et al. Retrospective diagnostics of congenital cytomegalovirus infection performed by polymerase chain reaction in blood stored on filter paper. Scand. J. Infect. Dis. 29 (1997) 465-468
17. Barbi M., et al. Cytomegalovirus DNA detection in Guthrie cards: a powerful tool for diagnosing congenital infection. J. Clin. Virol. 17 (2000) 159-165
18. Binda S., et al. Modification of CMV DNA detection from dried blood spots for diagnosing congenital CMV infection. J. Clin. Virol. 30 (2004) 276-279
19. Barbi M., et al. Neonatal screening for congenital cytomegalovirus infection and hearing loss. J. Clin. Virol. 35 (2006) 206-209
20. Distefano A.L., et al. Human cytomegalovirus: detection of congenital and perinatal infection in Argentina. BMC Pediatr. 4 (2004) 11
21. Yamamoto A.Y., et al. Usefulness of blood and urine samples collected on filter paper in detecting cytomegalovirus by the polymerase chain reaction technique. J. Virol. Methods 97 (2001) 159-164
22. Boppana S.B., et al. Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss. J. Pediatr. 146 (2005) 817-823
23. Bradford R.D., et al. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Detection of cytomegalovirus (CMV) DNA by polymerase chain reaction is associated with hearing loss in newborns with symptomatic congenital CMV infection involving the central nervous system. J. Infect. Dis. 191 (2005) 227-233
24. Lanari, M. et al. (2005). Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns. Pediatrics (Epub ahead of print)
25. Fowler K.B., et al. Maternal immunity and prevention of congenital cytomegalovirus infection. J. Am. Med. Assoc. 289 (2003) 1008-1011
26. Fowler K.B., et al. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N. Engl. J. Med. 326 (1992) 663-667
27. Revello M.G., and Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin. Microbiol. Rev. 15 (2002) 680-715
28. Schleiss M.R., and Heineman T.C. Progress toward an elusive goal: current status of cytomegalovirus vaccines. Expert Rev. Vaccines 4 (2005) 381-406
29. Adler S.P., et al. Prevention of child-to-mother transmission of cytomegalovirus among pregnant women. J. Pediatr. 145 (2004) 485-491
30. Nigro G., et al. Passive immunization during pregnancy for congenital cytomegalovirus infection. N. Engl. J. Med. 353 (2005) 1350-1362
31. Boppana S.B., et al. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N. Engl. J. Med. 344 (2001) 1366-1371
32. Adler S.P., et al. Prevention of child-to-mother transmission of cytomegalovirus by changing behaviors: a randomized controlled trial. Pediatr. Infect. Dis. J. 15 (1996) 240-246
33. Cannon M.J., and Davis K.F. Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health 5 (2005) 70
34. Schleiss M.R., and McVoy M.A. Overview of congenitally and perinatally acquired cytomegalovirus infections: recent advances in antiviral therapy. Expert Rev. Anti-Infect. Ther. 2 (2004) 389-403
35. Kimberlin D.W., et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J. Pediatr. 143 (2003) 16-25
36. Meine Jansen C.F., et al. Treatment of symptomatic congenital cytomegalovirus infection with valganciclovir. J. Perinat. Med. 33 (2005) 364-366
37. Schuknecht H.F. Pathology of the Ear. 2nd edn. (1993), Lea and Febiger
38. Davis G.L., et al. Cytomegalovirus endolabyrinthitis. Arch. Pathol. Lab. Med. 101 (1977) 118-121
39. Fukuda S., et al. Experimental cytomegalovirus infection: viremic spread to the inner ear. Am. J. Otolaryngol. 9 (1988) 135-141
40. Mocarski Jr. E.S. Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system. Cell Microbiol. 6 (2004) 707-717
41. Vink C., et al. Molecular mimicry by cytomegaloviruses. Function of cytomegalovirus-encoded homologues of G protein-coupled receptors, MHC class I heavy chains and chemokines. Intervirology 42 (1999) 342-349
42. Braud V.M., et al. Viral evasion of natural killer cells during human cytomegalovirus infection. Curr. Top. Microbiol. Immunol. 269 (2002) 117-129
43. Ulbrecht M., et al. Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis. J. Immunol. 164 (2000) 5019-5022
44. Tomasec P., et al. Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141. Nat. Immunol. 6 (2005) 181-188
45. Wills M.R., et al. Human cytomegalovirus encodes an MHC class I-like molecule (UL142) that functions to inhibit NK cell lysis. J. Immunol. 175 (2005) 7457-7465
46. Lurain N.S., et al. Human cytomegalovirus UL144 open reading frame: sequence hypervariability in low-passage clinical isolates. J. Virol. 73 (1999) 10040-10050
47. Arav-Boger R., et al. Polymorphisms of the cytomegalovirus (CMV)-encoded tumor necrosis factor-alpha and beta-chemokine receptors in congenital CMV disease. J. Infect. Dis. 186 (2002) 1057-1064
48. Gilbert M.J., et al. Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product. Nature 383 (1996) 720-722
49. Arnon T.I., et al. Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat. Immunol. 6 (2005) 515-523
50. Kotenko S.V., et al. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc. Natl. Acad. Sci. U S A 97 (2000) 1695-1700
51. Penfold M.E., et al. Cytomegalovirus encodes a potent alpha chemokine. Proc. Natl. Acad. Sci. U S A 96 (1999) 9839-9844
52. Akter P., et al. Two novel spliced genes in human cytomegalovirus. J. Gen. Virol. 84 Pt. 5 (2003) 1117-1122
53. Pinto A.K., and Hill A.B. Viral interference with antigen presentation to CD8+ T cells: lessons from cytomegalovirus. Viral Immunol. 18 (2005) 434-444
54. Guma M., et al. NK cell receptors involved in the response to human cytomegalovirus infection. Curr. Top. Microbiol. Immunol. 298 (2006) 207-223
55. Gerna G., et al. Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viral antigen presentation to CD8+ T cells. J. Gen. Virol. 86 Pt. 2 (2005) 275-284
56. Hahn G., et al. Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J. Virol. 78 (2004) 10023-10033
57. Ryckman B.J., et al. Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion. J. Virol. 80 (2006) 710-722
58. Wang D., and Shenk T. Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. Proc. Natl. Acad. Sci. U S A 102 (2005) 18153-18158
59. Elbou Ould M.A., et al. Cellular immune response of fetuses to cytomegalovirus. Pediatr. Res. 55 (2004) 280-286
60. Gibson L., et al. Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection. J. Immunol. 172 (2004) 2256-2264
61. Ryan A.F., et al. Immune-mediated hearing loss: basic mechanisms and options for therapy. Acta Otolaryngol. Suppl. 548 (2002) 38-43
62. Tu W., et al. Persistent and selective deficiency of CD4+ T cell immunity to cytomegalovirus in immunocompetent young children. J. Immunol. 172 (2004) 3260-3267
63. Keithley E.M., et al. Development of morphological and physiological changes in the cochlea induced by cytomegalovirus. Laryngoscope 99 (1989) 409-414
64. Woolf N.K., et al. Congenital cytomegalovirus labyrinthitis and sensorineural hearing loss in guinea pigs. J. Infect. Dis. 160 (1989) 929-937
65. Harris J.P., et al. Immunologic and electrophysiological response to cytomegaloviral (CMV) inner ear infection in the guinea pig. J. Infect. Dis. 150 (1984) 523-530
66. Woolf N.K., et al. Hearing loss in experimental cytomegalovirus infection of the guinea pig inner ear: prevention by systemic immunity. Ann. Otol. Rhinol. Laryngol. 94 4 Pt. 1 (1985) 350-356
67. Beadle J.R., et al. Alkoxyalkyl esters of cidofovir and cyclic cidofovir exhibit multiple-log enhancement of antiviral activity against cytomegalovirus and herpesvirus replication in vitro. Antimicrob. Agents Chemother. 46 (2002) 2381-2386
68. Woolf N.K., et al. Ganciclovir prophylaxis for cochlear pathophysiology during experimental guinea pig cytomegalovirus labyrinthitis. Antimicrob. Agents Chemother. 32 (1988) 865-872
69. White, D.R. et al., Effect of cidofovir on cytomegalovirus-induced hearing loss in a guinea pig model. Arch. Otolaryngol. Head Neck Surg. (in press)
70. Schleiss M.R. Role of breast milk in acquisition of cytomegalovirus infection: recent advances. Curr. Opin. Pediatr. 18 (2006) 48-52
71. Vollmer B., et al. Postnatally acquired cytomegalovirus infection via breast milk: effects on hearing and development in preterm infants. Pediatr. Infect. Dis. J. 23 (2004) 322-327
72. Schimmenti L.A., et al. Genetic testing as part of the early hearing detection and intervention (EHDI) process. Genet. Med. 6 (2004) 521-525